Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03572335 · ClinicalTrials.gov registry record
Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 61
- Enrollment target
NCT03572335 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 61 participants.
The verdict
NCT03572335 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
Diffusing capacity for carbon monoxide (DLco) abnormalities are common in HIV+ individuals and associated with significant morbidity and mortality. The complexity and the individualized differences in causes of these abnormalities have been challenging to unravel using traditional approaches. In this proposal, the investigators construct a systems' modeling approach to identify novel molecular and clinical pathways contributing to DLco impairment in HIV+ individuals and to determine predictive signatures of DLco decline in order to develop strategies to treat and prevent abnormal lung function in this susceptible population.
Interventions
- DIAGNOSTIC_TEST PFT's (pulmonary function testing)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2018-09-06 |
| Est. Completion | 2024-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03572335
The ClinicalTrials.gov registry entry for NCT03572335 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PFT's (pulmonary function testing) is the first listed.
NCT03572335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03572335 about?
NCT03572335 is a clinical study titled "Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)". Diffusing capacity for carbon monoxide (DLco) abnormalities are common in HIV+ individuals and associated with significant morbidity and mortality. The complexity and the individualized differences in causes of these abnormalities have been challenging to unravel using traditional approaches. In thi...
What is the current status of trial NCT03572335?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2018-09-06. Estimated completion is 2024-08-01.
What interventions are being tested in trial NCT03572335?
The interventions under investigation include: PFT's (pulmonary function testing) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03572335?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.